clinical trial · NCT06329661
A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine
Dry Eye DiseaseCyclosporine ophthalmic solution, 0.1%Saline solution, 0.6%
brief summary
The objective of this trial is to evaluate the effect of cyclosporine ophthalmic solution, 0.1% on corneal endothelial cell health in comparison to a hypotonic saline solution in subjects with Dry Eye Disease (DED)
started
Apr 22, 2024
primary completion
Jul 30, 2025
completion
Jul 30, 2025
last updated
Aug 27, 2025
detailed description
The effect of cyclosporine ophthalmic solution, 0.1% on corneal endothelial cell density (cells/mm²) will be evaluated in comparison to a hypotonic saline solution in subjects with DED after 12 months of treatment.
official title
A Multi-center, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Corneal Endothelial Health of Dry Eye Disease Subjects Treated With Cyclosporine Ophthalmic Solution, 0.1%
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol